Apolipoprotein E genotypes and risk of diabetic nephropathy

Journal of the American Society of Nephrology

Volumn 7, Issue 7, 1996, Pages 1075-1078

  Onuma, Tomio ^a   Laffel, Lori M B ^a   Angelico, M Clara ^a   Krolewski, Andrzej S ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b JOSLIN DIABETES CENTER   (United States)

Author keywords

Apolipoprotein E; Diabetic nephropathy; IDDM

Indexed keywords

APOLIPOPROTEIN E;

ADULT; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; DENATURING GRADIENT GEL ELECTROPHORESIS; DIABETIC NEPHROPATHY; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HEREDITY; HUMAN; HUMAN CELL; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; PRIORITY JOURNAL; PROTEINURIA;

EID: 0030367857     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Krolewski AS, Warram JH, Christlieb AR, Busick EJ, Kahn CR: The changing natural history of nephropathy in type I diabetes. Am J Med 1985;78:785-794
2. Andersen AR, Christiansen JS, Andersen JK, Kreiner S, Deckert T: Diabetic nephropathy in type I (insulin-dependent) diabetes: An epidemiologic study. Diabetologia 1983;25:496-501.
3. Telmer S, Sandahl J, Andersen AR, Nerup J, Deckert T: Smoking habits and prevalence of clinical diabetic microangiopathy in insulin-dependent diabetics. Acta Med Scand 1984;215:63-68.
4. Viberti GC, Keen H, Wiseman MJ: Raised arterial pressure in parents of proteinuric insulin dependent diabetics. Br Med J 1987;295:515-517.
5. Krolewski AS, Canessa M, Warram JH, et al.: Predisposition to hypertension and susceptibility to renal disease in insulin-dependent diabetes mellitus. N Engl J Med 1988;318:140-145.
6. Keane WF, Kasiske BL, O'Donnell MP: Lipids and progressive glomerulosclerosis: A model analogous to athirosclerosis. Am J Nephrol 1988;8:261-271.
7. Diamond JR: Analogous pathobiologic mechanisms in glomerulosclerosis and atherosclerosis. Kidney Int 1991; 39[Suppl 31]:S29-S34.
8. Krolewski AS, Warram JH, Chistlieb AR: Hypercholesterolemia: A determinant of renal function loss and deaths in IDDM patients with nephropathy. Kidney Int 1994;45[Suppl 45]:S125-S131.
9. Coonrod BA, Ellis D, Becker DJ, et al.: Predictors of microalbuminuria in individuals with IDDM. Diabetes Care 1993;16:1376-1383.
10. Wilson PW, Myers RH, Larson MG, Ordovas JM, Wolf PA, Schaefer EJ: Apolipoprotein E alleles, dyslipidemia, and coronary artery heart disease: The Framingham Offspring Study. JAMA 1994;272:1666-1671.
11. Mahley RW: Apolipoprotein E: Cholesterol transport protein with expanding role in cell biology. Science (Wash DC) 1988;240:622-630.
12. Winocour PH, Durrington PN, Ishola M, Anderson DC: Lipoprotein abnormalities in insulin dependent diabetes mellitus. Lancet 1986;1:1176-1178.
13. Eichner JE, Ferrell RE, Kamboh MI, et al.: The impact of the apolipoprotein E polymorphism on the lipoprotein profile in insulin-dependent diabetes: The Pittsburgh Epidemiology of Diabetes Complications Study IX. Metab Clin Exp Med 1992;41:347-351.
14. Parker S, Angelico MC, Laffel L, Krolewski AS: Application of denaturing gradient gel electrophoresis to detect DNA sequence differences encoding apolipoprotein E isoforms. Genomics 1993;16:245-247.
15. Black SC, Hewett S, Kotubi Y, Brunt RV, Reckless JPD: Isoform patterns of apolipoprotein E in diabetes mellitus. Diabetic Med 1990;7:532-539.
16. Curtiss LK, Witztum JL: Plasma apolipoproteins AI, AII, B, CI and E are glucosylated in hyperglycemic diabetic subjects. Diabetes 1985;34:452-461.
17. Barzilay J, Warram JH, Bak M, Laffel LMB, Canessa M, Krolewski AS: Predisposition to hypertension: Risk factor for nephropathy and hypertension in IDDM. Kidney Int 1992;41:723-730.
18. Brodows RG, Nicholls G, Shaker G, Kubasik NP: Evaluation of a new radioimmunoassay for urinary albumin. Diabetes Care 1986;9:189-193.
19. Emi M, Wu LL, Robertson MA, et al.: Genotyping and sequence analysis of apolipoprotein E isoforms. Genomics 1988;3:373-379.
20. Krolewski AS, Krolewski B, Gray M, Stanton V, Warram JH, Housman D: High-frequency DNA sequence polymorphisms in the insulin receptor gene detected by denaturing gradient gel blots. Genomics 1992;12:705-709.
21. Davignon J, Gregg RE, Sing CF: Apolipoprotein E polymorphism and atherosclerosis. Atherosclerosis 1988;8:1-21.
22. Diamond JR, Karnovsky MJ: Exacerbation of chronic aminonucleoside nephrosis by dietary cholesterol. Kidney Int 1987;12:671-677.
23. Kasiske BL, O'Donnell MP, Cowardin W, Keane WF: Lipids and the kidney. Hypertension (Dallas) 1990;15:443-450.
24. Keane WF, Kasiske BL O'Donnel MP, Kim Y: Hypertension hyperlipidemia, and renal damage. Am J Kidney Dis 1993;21[Suppl 2]:43-50.
25. Eto M, Watanabe K, Makino I, Ishii K: Apolipoprotein E allele frequencies in non-insulin-dependent diabetes mellitus with hypertriglyceridemia (type IIb, III, IV, and V hyperlipoproteinemia). Metab Clin Exp Med 1991;40:776-780.
26. Eto M, Watanabe K, Iwashima Y: Apolipoprotein E polymorphism and hyperlipidemia in type II diabetics. Diabetes 1986;35:1374-1382.
27. Dunn FL, Pietri A, Raskin P: Plasma lipid and lipoprotein levels with continuous subcutaneous insulin infusion in type I diabetes mellitus. Ann Intern Med 1981; 95:426-431.
28. Attman PO, Samuelsson O, Alaupovic P: Lipoprotein metabolism and renal failure. Am J Kidney Dis 1993;21:573-592.
29. Wasserman J, Santiago A, Rifici V, et al.: Interaction of low density lipoprotein with rat mesangial cells. Kidney Int 1989;35:1168-1174.
30. Laakso M, Kesaniemi A, Kervinen K, Jauhiainen M, Pyorala K: Relation of coronary heart disease and apolipoprotein E phenotype in patients with non-insulin dependent diabetes. BMJ 1991;303:1159-1162.
31. Ukkola O, Kervinen K, Salmela PI, Dickhoff KV, Laakso M Kesaniemi YA: Apolipoprotein E phenotype is related to macro- and microangiopathy in patients with non-insulin dependent diabetes mellitus. Atherosclerosis 1993;101:9-15
32. Horita K, Eto M, Makino I: Apolipoprotein E2, renal failure and lipid abnormalities in non-insulin-dependent diabetes mellitus. Atherosclerosis 1994;107:203-211.
33. Corticelli P, Benhamou PY, Foulon M, et al.: Apolipoprotein E polymorphism and diabetic nephropathy [Abstract]. 15th International Diabetes Federation Congress, Kobe, Japan, 1994:127A.
34. Okamura M, Miyauchi A, Ishida S, et al.: Apolipoprotein E polymorphism in non-insulin dependent diabetic patients: Association with serum lipid, glycemic control and diabetic microangiopathy [Abstract]. 15th International Diabetes Federation Congress, Kobe, Japan, 1994: 265A.
35. Kawahara R, Yoshino M, Amemiya T, et al.: Apolipoprotein E phenotype is associated with micro- and macroangiopathy in NIDDM patients [Abstract]. 15th International Diabetes Federation Congress, Kobe, Japan, 1994: 265A.